ESC 365 - Anticoagulants in cardiovascular disease – from basics to translation

Open Access

Anticoagulants in cardiovascular disease – from basics to translation

Event: Frontiers in CardioVascular Biology 2016

Topic: Miscellaneous

Session type: Symposium

Date: 8 July 2016

Time: 12:45 - 14:45

Session

6 presentations in this session

Thrombosis revisited: the role of platelets and thrombin in venous and arterial thrombosis.

Speaker: Professor A. Siegbahn (Uppsala, SE)

Anticoagulation therapy in 2016 and beyond: from theory to practice.

Speaker: Doctor J. Weitz (Hamilton, CA)

NOACs for treatment of venous thromboembolism: where are we, and where are we going?

Speaker: Professor W. Ageno (Varese, IT)

NOACs in atrial fibrillation and coronary heart disease: where are we and where are we going?

Speaker: Professor R. De Caterina (Pisa, IT)

Monitoring NOACs: heresy or care refinement?

Speaker: Doctor M. Levi (Amsterdam, NL)

Reversal of non-vitamin K antagonist oral anticoagulants: true need or perception in search of solutions.

Speaker: Doctor J. Van Ryn (Biberach, DE)

6 speakers from this session

Professor Agneta Siegbahn

Uppsala University, Uppsala (Sweden)

1 presentation

0 follower

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

20 presentations

0 follower

Professor Walter Ageno

University of Insubria, Varese (Italy)

3 presentations

0 follower

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)

25 presentations

1 follower

Doctor Marcel M Levi

, Amsterdam (Netherlands (The))

1 presentation

0 follower

Doctor Joanne Van Ryn

Boehringer Ingelheim Pharma GmbH & Co KG, Biberach (Germany)

1 presentation

0 follower

This platform is supported by